Science Explorer Back to mapMap
Discussion
Researcher · Ambrx (United States) · United States

Nick A. Knudsen

Nick A. Knudsen publishes mostly in Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology, on topics such as Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research and Radiopharmaceutical Chemistry and Applications.

ORCID 0009-0004-7026-0366 OpenAlex
World rank
#1,239,886
of 7,710,434 ranked researchers
Rank in United States
#396,375
of 1,627,098
Works
31
Citations
867
Citations per work
28.0
h-index
9
i10-index 9Top 62% in Radiology, Nuclear Medicine and Imaging
Nick A. Knudsen

What does Nick A. Knudsen research?

Nick A. Knudsen's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (8%).

Health Sciences: 17 works · 54.9% of their workMedicine: 17 works · 54.9% of their workRadiology, Nuclear Medicine and Imaging: 9 works · 29.0% of their workOncology: 6 works · 19.4% of their workImmunology and Allergy: 2 works · 6.5% of their workLife Sciences: 7 works · 22.6% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 14.5% of their workMolecular Biology: 3 works · 9.7% of their workBiotechnology: 1 works · 4.8% of their workImmunology and Microbiology: 3 works · 8.1% of their workImmunology: 3 works · 8.1% of their workEverything else: 7 works · 22.5% of their workTHEIR WORKNick A. Knudsen31works
Life Sciences23%Health Sciences55%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1754.9%
    1. Biochemistry, Genetics and Molecular Biology414.5%
    2. Immunology and Microbiology38.1%
  3. Everything else722.5%
  1. 1Radiology, Nuclear Medicine and Imaging29% of their works
  2. 2Oncology19% of their works
  3. 3Molecular Biology10% of their works
  4. 4Immunology8% of their works
  5. 5Immunology and Allergy6% of their works
  6. 6Biotechnology5% of their works

Research topics

Which keywords describe Nick A. Knudsen's research?

The keywords of their largest research topics: Monoclonal Antibodies, Glycosylation, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Monoclonal Antibody, Breast Cancer and HER2.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Monoclonal Antibodies173 topics
  2. Glycosylation142 topics
  3. Therapeutic Antibodies142 topics
  4. Antibody Engineering121 topic
  5. Fc Receptors121 topic
  6. Monoclonal Antibody112 topics
  7. Breast Cancer91 topic
  8. HER291 topic
  9. PET Imaging61 topic
  10. Radiopharmaceuticals61 topic
  11. Biopharmaceuticals52 topics
  12. Immunogenicity52 topics
  13. Cell Adhesion41 topic
  14. Integrins41 topic
  15. Bacterial Therapy31 topic
  16. Bioanalytical Methods31 topic
  17. Biosimilars31 topic
  18. Tumor Targeting31 topic
  19. Mammalian Cells21 topic
  20. Protein Aggregation21 topic
  21. Recombinant Protein21 topic
  22. Recombinant Proteins21 topic

Where does Nick A. Knudsen work?

Nick A. Knudsen's main affiliation in the publication record is Ambrx (United States), United States.

How many publications and citations does Nick A. Knudsen have?

OpenAlex counts 31 works and 867 citations for Nick A. Knudsen, an h-index of 9, ranking #1,239,886 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Nick A. Knudsen. Posts are plain text and can be reported.